Stericycle Inc. (SRCL) Upgraded to Hold at Zacks Investment Research
According to Zacks, “Stericycle has a negative earnings surprise history, having missed estimates twice in the trailing four quarters. The recent spate of acquisitions is leading to higher overheads and integration-related expenses, which are weighing on margins. The company faces aggressive price wars that erode its profitability. Evolving environmental rules and regulations remain another headwind. Stericycle also lowered its earnings guidance for 2016 due to macroeconomic challenges. However, Stericycle’s network is the largest in the industry and provides it with routing efficiencies for its vehicles from the customer sites to the collection and processing facilities. The acquisition pool of the company also remains robust in multiple geographies and lines of business. International growth rates are expected to accelerate due to increasing customer adoption of multiple services and expansion into new lines of business.”
SRCL has been the subject of several other reports. Macquarie began coverage on shares of Stericycle in a research note on Thursday, August 25th. They issued a neutral rating and a $96.00 target price for the company. Jefferies Group reiterated a buy rating and issued a $112.50 target price (down from $125.00) on shares of Stericycle in a research note on Wednesday, September 7th. Imperial Capital cut shares of Stericycle from an in-line rating to an underperform rating and decreased their target price for the company from $100.00 to $93.50 in a research note on Friday, July 29th. Wellington Shields cut shares of Stericycle from an accumulate rating to a hold rating in a research note on Friday, July 29th. Finally, Wedbush decreased their target price on shares of Stericycle from $95.00 to $85.00 and set a neutral rating for the company in a research note on Thursday, September 22nd. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have issued a buy rating to the stock. The company presently has an average rating of Hold and an average target price of $104.95.
Stericycle (NASDAQ:SRCL) traded down 0.215% during trading on Wednesday, reaching $81.355. 90,476 shares of the company’s stock traded hands. Stericycle has a one year low of $76.76 and a one year high of $151.57. The firm has a market capitalization of $6.92 billion, a PE ratio of 28.636 and a beta of 0.27. The company has a 50-day moving average price of $83.25 and a 200 day moving average price of $101.19.
Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.18. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. The firm earned $891.60 million during the quarter, compared to analysts’ expectations of $910.29 million. During the same period in the previous year, the business posted $1.14 EPS. The business’s revenue was up 24.6% compared to the same quarter last year. On average, analysts anticipate that Stericycle will post $4.67 earnings per share for the current fiscal year.
In related news, Director Mark C. Miller sold 34,835 shares of the company’s stock in a transaction that occurred on Friday, July 8th. The shares were sold at an average price of $104.52, for a total transaction of $3,640,954.20. Following the sale, the director now directly owns 244,284 shares in the company, valued at $25,532,563.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP John P. Schetz sold 1,398 shares of the company’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the sale, the executive vice president now owns 1,088 shares in the company, valued at $89,052.80. The disclosure for this sale can be found here. Insiders own 3.30% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in the company. Balentine LLC raised its stake in Stericycle by 15.0% in the second quarter. Balentine LLC now owns 1,224 shares of the company’s stock worth $127,000 after buying an additional 160 shares during the last quarter. Pinkerton Retirement Specialists LLC purchased a new stake in Stericycle during the second quarter worth $131,000. Parkside Financial Bank & Trust raised its stake in Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock worth $149,000 after buying an additional 41 shares during the last quarter. Meeder Asset Management Inc. purchased a new stake in Stericycle during the second quarter worth $155,000. Finally, Canada Pension Plan Investment Board raised its stake in Stericycle by 54.1% in the first quarter. Canada Pension Plan Investment Board now owns 1,415 shares of the company’s stock worth $179,000 after buying an additional 497 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.